Point: Parametrial irradiation in locally advanced cervix cancer can be achieved effectively with a variety of external beam techniques

Brachytherapy

Volumn 11, Issue 2, 2012, Pages 77-79

  Good, James ^a   Lalondrelle, Susan ^a   Blake, Peter ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE TOXICITY; ADVANCED CANCER; ARTICLE; BRACHYTHERAPY; CHEMORADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; CYBERKNIFE; EXTERNAL BEAM RADIOTHERAPY; GASTROINTESTINAL TOXICITY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; ION THERAPY; NEUTROPENIA; PRIORITY JOURNAL; PROTON THERAPY; RADIATION DOSE DISTRIBUTION; STEREOTACTIC RADIOSURGERY; UTERINE CERVIX CANCER;

BRACHYTHERAPY; CERVIX UTERI; FEMALE; HUMANS; NEOPLASM INVASIVENESS; RADIOTHERAPY DOSAGE; UTERINE CERVICAL NEOPLASMS; UTERUS;

EID: 84857743209     PISSN: 15384721     EISSN: 18731449     Source Type: Journal    
DOI: 10.1016/j.brachy.2012.01.003     Document Type: Article

References (29)

1. Hockel M., Schlenger K., Aral B., et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996, 46:4509-4515.
2. Dehdashti F., Grigsby P.W., Mintun M.A., et al. Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: Relationship to therapeutic response-A preliminary report. Int J Radiat Oncol Biol Phys 2003, 55:1233-1238.
3. Hanahan D., Weinberg R. Hallmarks of cancer: The next generation. Cell 2001, 14:646-674.
4. Perez C.A., Grigsby P.W., Chao K.S., et al. Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix. Int J Radiat Oncol Biol Phys 1998, 41:307-317.
5. van den Tillaart S.A.H.M., Trimbos J.B.M.Z., Dreef E.J., et al. Patterns of parametrial involvement in radical hysterectomy specimens of cervical cancer patients. Int J Gynecol Pathol 2011, 30:185-192.
6. Logsdon M.D., Eifel P.J. FIGO IIIB squamous cell carcinoma of the cervix: An analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys 1999, 43:763-773.
7. Potter R., Maie-Meder C., van Limbergen E., et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D Dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006, 78:67-77.
8. Wolfson A.H., Abdel-Wahab M., Markoe A.M., et al. A quantitative assessment of standard vs. customised midline shield construction for invasive cervical carcinoma. Int J Radiat Oncol Biol Phys 1997, 37:237-242.
9. Huang E.Y., Lin H., Hsu H.C., et al. High external parametrial dose can increase the probability of radiation proctitis in patient with uterine cervical cancer. Gynecol Oncol 2000, 79:406-410.
10. Fenkell L., Assenholt M., Nielsen S.K., et al. Parametrial boost using midline shielding results in an unpredictable dose to tumor and organs at risk in combined external beam radiotherapy and brachytherapy for locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 2011, 79:1572-1579.
11. Portelance L., Chao K.S.C., Grigsby P.W., et al. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys 2001, 51:261-266.
12. Heron D.E., Gerszten K., Selvaraj R.N., et al. Conventional 3D conformal versus intensity-modulated radiotherapy for the adjuvant treatment of gynaecologic malignancies: A comparative dosimetric study of dose-volume histograms. Gynecol Oncol 2003, 91:39-45.
13. Mell L.K., Tiryaki H., Ahn K.H., et al. Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer. Int J Radiat Oncol Biol Phys 2008, 71:1504-1510.
14. Mundt A.J., Mell L.K., Roeske J.C. Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. Int J Radiat Oncol Biol Phys 2003, 56:1354-1360.
15. Brixey C.J., Roeske J.C., Lujan A.E., et al. Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynaecologic malignancies. Int J Radiat Oncol Biol Phys 2002, 54:1388-1396.
16. Ahmed R.S., Kim R.Y., Duan J., et al. IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk. Int J Radiat Oncol Biol Phys 2004, 60:505-512.
17. Cozzi L., Dinshaw K.A., Shrivastava S.K., et al. A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy. Radiother Oncol 2008, 89:180-191.
18. Vandecasteele K., de Neve W., de Gersem W., et al. Intensity-modulated arc therapy with simultaneous integrated boost in the treatment of primary irresectable cervical cancer. Strahlenther Onkol 2009, 12:799-807.
19. Erickson B., Eifel P., Moughan J., et al. Patterns of brachytherapy practice for patient with carcinoma of the cervix (1996-1999): A patterns of care study. Int J Radiat Oncol Biol Phys 2005, 63:1083-1092.
20. Mell L.K., Malhotra A.K., Mundt A.J. Intensity-modulated radiation use in the US, 2004. Cancer 2005, 104:1296-1303.
21. Assenholt M.S., Petersen J.B., Nielsen S.K. A dose planning study on applicator guided stereotactic IMRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer. Acta Oncol 2008, 47:1337-1343.
22. Gielda B.T., Shah A.P., Marsh J.C., et al. Helical tomotherapy delivery of an IMRT boost in lieu of interstitial brachytherapy in the setting of gynaecologic malignancy: Feasibility and dosimetric comparison. Med Dosim 2011, 36:206-212.
23. Georg P., Kirisits C., Goldner G., et al. Correlation of dose-volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy. Radiother Oncol 2009, 91:173-180.
24. Molla M., Escude L., Nouet P., et al. Fractionated stereotactic radiotherapy boost for gynecologic tumors: An alternative to brachytherapy?. Int J Radiat Oncol Biol Phys 2005, 62:118-124.
25. Hsieh C.H., Wei M.C., Hsu Y.P., et al. Should helical tomotherapy replace brachytherapy for cervical cancer? Case report. BMC Cancer 2010, 10:637.
26. Nakano T., Suzuki Y., Ohno T., et al. Carbon beam therapy overcomes the radiation resistance of uterine cervix cancer originating from hypoxia. Clin Caner Res 2006, 12:2185-2190.
27. Georg D., Georg P., Hillbrand M., et al. Assessment of improved organ at risk sparing for advanced cervix cancer utilizing precision radiation techniques. Strahlenther Onkol 2008, 184:586-591.
28. Smit B.M. Prospects for proton therapy in carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1991, 22:349-353.
29. Kagei K., Tokuuye K., Okumura T., et al. Long term results of proton beam therapy for carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 2003, 55:1265-1271.